ISCT and CMaT Announce Upcoming Course Dates for Successful Workforce Development in Biomanufacturing
The International Society for Cell & Gene Therapy (ISCT) and the NSF Engineering Research Center for Cell Manufacturing Technologies (CMaT) developed the Workforce Development in Biomanufacturing course to address workforce shortages in cellular therapies. Workforce shortages was a major topic of discussion at the 2022 FACT Regenerative Medicine InterCHANGE, and this program was highlighted as a potential solution.
Developed by academic, regulatory, clinical, and commercial experts, this program upskills key personnel for roles across the cell and gene therapy sector with modules including:
- Module 1: Stem Cell and Immune Cell Engineering and Therapies
- Module 2: Quality Assurance and Regulatory Framework
- Module 3: Cell Bioprocessing and Manufacturing
- Module 4: Cell Product Characterization and Importance of Standards
The inaugural course received positive reviews and attendees indicated that they would recommend the course to colleagues. Visit the ISCT website for detailed information on course dates, format, registration, and fee discounts.